18 - 19 April 2012
InterContinental Hotel, Nairobi, Kenya
Dr. Terry R. Knapp
CEO/CMO, Magellan Global Health, Inc.
Dr. Knapp has a 40-year record of achievement in health care and business. In 1970, he completed his MD degree at University of Florida, where he was a member of Alpha Omega Alpha honor society and received the faculty’s highest award at graduation, the John Gorrie Award ("Most Promise for Becoming a Physician of the Highest Type"). While in specialty training at Stanford University, Dr. Knapp developed and patented the enabling technology for Collagen Corporation (CGEN - NASDAQ), which he co-founded in 1975. While serving as Collagen’s first VP of Regulatory and Clinical Affairs, he developed the clinical and regulatory strategies that resulted in the first U.S. product approval by the FDA of a Class III medical device under the Medical Device Act of 1976. He served as a Director of Collagen from 1990 – 1996. He currently serves on the boards of several private medical and engineering companies. Dr. Knapp also has co-founded, and serves as President of the DRL Foundation, a not-for-profit foundation providing reconstructive surgery for children and telehealth to developing nations. In 1998, Dr. Knapp became the eighteenth graduate in the history of the University of Florida College of Medicine to be inducted into its Wall of Fame “for noteworthy contributions to medicine, education and to the benefit of the medical consumer.” Currently, he serves as Chairman, CEO and Chief Medical Officer of Magellan Global Health, Inc., a multinational, early stage telehealth and global health care delivery company.
Telemedicine: Opportunities and Challenges